Does EVEROLIMUS Cause Neoplasm progression? 647 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 647 reports of Neoplasm progression have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 1.6% of all adverse event reports for EVEROLIMUS.
647
Reports of Neoplasm progression with EVEROLIMUS
1.6%
of all EVEROLIMUS reports
112
Deaths
140
Hospitalizations
How Dangerous Is Neoplasm progression From EVEROLIMUS?
Of the 647 reports, 112 (17.3%) resulted in death, 140 (21.6%) required hospitalization, and 29 (4.5%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 647 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which EVEROLIMUS Alternatives Have Lower Neoplasm progression Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE